Technical Analysis for OXFD - Oxford Immunotec Global PLC
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
 |
14.55 | 3.05% | 0.43 |
OXFD closed up 3.05 percent on Friday, September 20, 2019, on approximately normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
Earnings due: Sep 27
*** please verify all earnings dates ***| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Weak or Absent | Down | Up | Up |
| See historical OXFD trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| Stochastic Sell Signal | Bearish | 3.05% | |
| Narrow Range Bar | Range Contraction | 3.05% | |
| NR7 | Range Contraction | 3.05% | |
| NR7-2 | Range Contraction | 3.05% | |
| Upper Bollinger Band Walk | Strength | 3.05% |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 09/27/2019
- Sector: Healthcare
- Industry: Diagnostics & Research
Oxford Immunotec Global PLC, a diagnostics company, focuses on the provision of various innovative tests in the field of immunology in the United States, Europe, Japan, and China. The company develops its products using its T-SPOT technology platform, which allows to measure the responses of specific immune cells to inform the diagnosis, prognosis, and monitoring of patients with immunologically controlled diseases. Its solution includes SPOT.TB test, a single-cell based method for identifying latent tuberculosis infection. The company was founded in 2013 and is headquartered in Abingdon, the United Kingdom.
Medicine Health Medical Specialties Immunology Infection Tuberculosis Its Its Products
Medicine Health Medical Specialties Immunology Infection Tuberculosis Its Its Products
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more OXFD news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 19.19 |
| 52 Week Low | 11.88 |
| Average Volume | 146,687 |
| 200-Day Moving Average | 14.7992 |
| 50-Day Moving Average | 13.5018 |
| 20-Day Moving Average | 13.591 |
| 10-Day Moving Average | 13.855 |
| Average True Range | 0.4527 |
| ADX | 18.03 |
| +DI | 26.8659 |
| -DI | 10.8877 |
| Chandelier Exit (Long, 3 ATRs ) | 13.2719 |
| Chandelier Exit (Short, 3 ATRs ) | 14.1681 |
| Upper Bollinger Band | 14.3879 |
| Lower Bollinger Band | 12.7941 |
| Percent B (%b) | 1.1 |
| BandWidth | 11.726878 |
| MACD Line | 0.1702 |
| MACD Signal Line | 0.0549 |
| MACD Histogram | 0.1153 |
| Fundamentals | Value |
|---|---|
| Market Cap | 335.76 Million |
| Num Shares | 23.1 Million |
| EPS | -1.50 |
| Price-to-Earnings (P/E) Ratio | -9.70 |
| Price-to-Sales | 3.67 |
| Price-to-Book | 6.80 |
| PEG Ratio | 0.00 |
| Dividend | 0.00 |
| Dividend Yield | 0.00% |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 15.36 | ||||
| Resistance 3 (R3) | 15.30 | 14.96 | 15.23 | ||
| Resistance 2 (R2) | 14.96 | 14.76 | 15.00 | 15.18 | |
| Resistance 1 (R1) | 14.76 | 14.63 | 14.86 | 14.82 | 15.13 |
| Pivot Point | 14.42 | 14.42 | 14.48 | 14.46 | 14.42 |
| Support 1 (S1) | 14.22 | 14.22 | 14.32 | 14.28 | 13.97 |
| Support 2 (S2) | 13.88 | 14.09 | 13.92 | 13.92 | |
| Support 3 (S3) | 13.68 | 13.88 | 13.88 | ||
| Support 4 (S4) | 13.74 |
